Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITAPIVAT vs MITOXANTRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITAPIVAT vs MITOXANTRONE: Safety Overview

Metric MITAPIVAT MITOXANTRONE
Total FAERS Reports 627 4,166
Deaths Reported 4 995
Death Rate 0.6% 23.9%
Hospitalizations 58 1,556
Average Patient Age 46.6 yrs 37.0 yrs
% Female Patients 53.5% 48.0%
FDA Approval Date Dec 23, 2025 Apr 11, 2006
Manufacturer Agios Pharmaceuticals, Inc. Meitheal Pharmaceuticals Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued